Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Jordan

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|May 23, 2020
High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan AfricaSeth C Inzaule, Michael R Jordan, George Bello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, IndiaNitin K Hingankar, Smita R Thorat, Alaka Deshpande, et al.
Medicine|September 14, 2020
High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in NamibiaMichael R Jordan, Ndapewa Hamunime, Leonard Bikinesi, et al.
Scientific Reports|November 22, 2023
High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es SalaamGeorge M Bwire, Beatrice Godwin Aiko, Idda H Mosha, et al.
Plos One|March 7, 2009
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 updateDiane E Bennett, Ricardo J Camacho, Dan Otelea, et al.
Antiviral Therapy|August 17, 2022
Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in MalawiGeorge Bello, Matthew Kagoli, Sikhona Chipeta, et al.
Plos One|July 29, 2017
Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretationRoger Paredes, Philip L Tzou, Gert van Zyl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment programNellie Wadonda-Kabondo, Diane Bennett, Joep J van Oosterhout, et al.
Journal of the International AIDS Society|February 23, 2022
The prevalence of pre-treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017-2018Vu Quoc Dat, Nguyen Thi Lan Anh, Khuu Van Nghia, et al.
Viruses|June 26, 2026
Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-Defined ScenariosRobert W Shafer, Kaiming Tao, Tom Loosli, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|May 23, 2020
High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan AfricaSeth C Inzaule, Michael R Jordan, George Bello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, IndiaNitin K Hingankar, Smita R Thorat, Alaka Deshpande, et al.
Medicine|September 14, 2020
High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in NamibiaMichael R Jordan, Ndapewa Hamunime, Leonard Bikinesi, et al.
Scientific Reports|November 22, 2023
High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es SalaamGeorge M Bwire, Beatrice Godwin Aiko, Idda H Mosha, et al.
Plos One|March 7, 2009
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 updateDiane E Bennett, Ricardo J Camacho, Dan Otelea, et al.
Antiviral Therapy|August 17, 2022
Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in MalawiGeorge Bello, Matthew Kagoli, Sikhona Chipeta, et al.
Plos One|July 29, 2017
Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretationRoger Paredes, Philip L Tzou, Gert van Zyl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment programNellie Wadonda-Kabondo, Diane Bennett, Joep J van Oosterhout, et al.
Journal of the International AIDS Society|February 23, 2022
The prevalence of pre-treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017-2018Vu Quoc Dat, Nguyen Thi Lan Anh, Khuu Van Nghia, et al.
Viruses|June 26, 2026
Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-Defined ScenariosRobert W Shafer, Kaiming Tao, Tom Loosli, et al.
Pageof 11